| Drug Type TCR-T Cell therapy | 
| Synonyms GB 3010, GB-3010 | 
| Target | 
| Action inhibitors | 
| Mechanism RAS inhibitors(RAS type GTPase family inhibitors) | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Pancreatic Cancer | Phase 1 | China  | 07 Sep 2021 | 





